Tsumura Overview
- Year Founded
-
1893
- Status
-
Public
- Employees
-
5,809
- Stock Symbol
-
4540
- Investments
-
7
- Share Price
-
$24.67
- (As of Friday Closing)
Tsumura General Information
Description
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates the majority of its revenue through prescription Kampo products, followed by over-the-counter medicines. It promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company specializes in developing, producing, and marketing Kampo formulations that integrate traditional herbal knowledge with modern pharmaceutical science to address various health conditions.
Contact Information
Website
www.tsumura.co.jpCorporate Office
- 2-17-11 Akasaka, Minato-ku
- Tokyo, 107-8521
- Japan
Corporate Office
- 2-17-11 Akasaka, Minato-ku
- Tokyo, 107-8521
- Japan
Tsumura Stock Performance
As of 13-Nov-2026, Tsumura’s stock price is $24.67. Its current market cap is $1.84B with 74.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $24.67 | $24.50 | $22.34 - $28.08 | $1.84B | 74.6M | 502K | $2.71 |
Tsumura Financials Summary
As of 30-Sep-2026, Tsumura has a trailing 12-month revenue of $1.31B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,572,814 | 2,367,603 | 2,348,529 | 2,073,039 |
| Revenue | 1,309,912 | 1,277,924 | 1,187,510 | 1,043,983 |
| EBITDA | 396,877 | 362,090 | 371,277 | 236,342 |
| Net Income | 202,327 | 186,545 | 212,645 | 115,628 |
| Total Assets | 4,176,189 | 3,708,079 | 3,103,266 | 2,829,561 |
| Total Debt | 970,753 | 845,500 | 470,027 | 526,528 |
Tsumura Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tsumura Patents
Tsumura Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026156412-A | Fastener opening and closing device, method, and program | Pending | 19-Mar-2025 | ||
| JP-2026127463-A | Bioassay method for hange-shashin-to using pharmacological activity as an indicator | Pending | 27-Jan-2025 | ||
| US-20260219260-A1 | Bioassay method for hangeshashinto using pharmacological activity as indicator | Pending | 27-Jan-2025 | ||
| JP-2025152228-A | Method for cultivating panax ginseng seedlings | Pending | 28-Mar-2024 | ||
| JP-2025143728-A | Anti-rs virus agent | Pending | 19-Mar-2024 |
Tsumura Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tsumura Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tsumura Investments & Acquisitions (7)
Tsumura’s most recent deal was a Merger/Acquisition with Shanghai Hongqiao Traditional Chinese Medicine Pieces for . The deal was made on 08-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Shanghai Hongqiao Traditional Chinese Medicine Pieces | 08-Aug-2025 | Merger/Acquisition | Pharmaceuticals | ||
| Life Care Pharmaceuticals | 23-Apr-2023 | Merger/Acquisition | Pharmaceuticals | ||
| Tsumura Pharmaceutical | 31-Mar-2020 | Merger/Acquisition | Pharmaceuticals | ||
| China Medico Technology | 06-Nov-2019 | Merger/Acquisition | Pharmaceuticals | ||
| My Farm | 10-May-2018 | Seed Round | Other Agriculture |
Tsumura ESG
Risk Overview
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Tsumura Exits (1)
Tsumura’s most recent exit was on 23-Apr-2023 from Life Care Pharmaceuticals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Life Care Pharmaceuticals | 23-Apr-2023 | Completed |
|
Tsumura Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Tsumura Pharmaceutical | Tianjin, China | 2011 |
Tsumura FAQs
-
When was Tsumura founded?
Tsumura was founded in 1893.
-
Where is Tsumura headquartered?
Tsumura is headquartered in Tokyo, Japan.
-
What is the size of Tsumura?
Tsumura has 5,809 total employees.
-
What industry is Tsumura in?
Tsumura’s primary industry is Pharmaceuticals.
-
Is Tsumura a private or public company?
Tsumura is a Public company.
-
What is Tsumura’s stock symbol?
The ticker symbol for Tsumura is 4540.
-
What is the current stock price of Tsumura?
As of 13-Nov-2026 the stock price of Tsumura is $24.67.
-
What is the current market cap of Tsumura?
The current market capitalization of Tsumura is $1.84B.
-
What is Tsumura’s current revenue?
The trailing twelve month revenue for Tsumura is $1.31B.
-
What is Tsumura’s annual earnings per share (EPS)?
Tsumura’s EPS for 12 months was $2.71.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
